What Researchers Did
Researchers conducted a systematic review of clinical papers published between 1966 and 2003 to evaluate the use of adjuvant hyperbaric oxygen therapy (HBO) for crush injury and traumatic ischemia.
What They Found
The review identified nine clinical papers, encompassing approximately 150 patients, with most being retrospective, uncontrolled case series (Class III evidence). Eight of these nine studies indicated a beneficial effect from adjuvant HBO therapy, with only one major complication reported across all included studies.
What This Means for Canadian Patients
For Canadian patients experiencing severe crush injury or traumatic ischemia, this review suggests that early administration of hyperbaric oxygen therapy (HBO) could be beneficial and is unlikely to cause harm. While the evidence quality is low, it indicates HBO might be a useful adjunctive treatment option to discuss with their care team.
Canadian Relevance
This study has no direct Canadian connection or specific Canadian data.
Study Limitations
The primary limitation is that most included studies were retrospective, uncontrolled case series with low evidence quality, and the single randomized trial had design limitations.